Conciseness

The bulk is high-value, non-obvious domain content (QC thresholds, evidence-grading criteria, expected-aggregation-level gotchas like 'the expected GT is almost always the sgRNA-level Spearman'). Minor trimming is possible: the 'Overview' bullet list duplicates the 'Core Workflow' phases, and the opening 'Comprehensive skill for analyzing...' paragraph is filler — 'efficient; minor instances of over-explanation that could be trimmed', not the noticeably padded level 3.

Actionability

Concrete guidance exists (tool names with parameters, exact tu run commands, thresholds like 'LFC < -0.5' and 'recovery_rate >~0.8'), but the Quick Start code calls helper functions — load_sgrna_counts, filter_low_count_sgrnas, mageck_gene_scoring, prioritize_drug_targets — that are defined nowhere in the bundle (the ANALYSIS_DETAILS.md that would hold them is missing), making it effectively pseudocode. This matches anchor 3: 'some concrete guidance but incomplete; pseudocode instead of executable code'.

Workflow Clarity

The 8-phase workflow is clearly numbered and sequenced, and RULE ZERO plus QC gates (core-essential recovery check, 'their absence from the hit list indicates a QC problem') provide real validation checkpoints — above anchor 3. It falls short of anchor 5 because recovery actions after a failed check are implied rather than given as explicit validate→fix→retry loops, and the fallback-pattern file referenced for API failures is absent.

Progressive Disclosure

Section structure is good and the scripts/ bundle files referenced in the body (reference_gene_sets.py, CEGv2/NEGv1 sets) are real, but the entire 'See Also' layer — ANALYSIS_DETAILS.md, USE_CASES.md, EXAMPLES.md, QUICK_START.md, FALLBACK_PATCH.md — plus the mentioned '.gmt' bundle do not exist in the bundle. The primary detail references are clearly signaled but broken, so navigation does not hold up; this is anchor 3 ('some structure but could be better organized; references present but not clearly signaled') rather than 4's 'minor organization gaps', since 5 of the referenced files are missing.

Specificity

Lists multiple concrete actions — 'MAGeCK gene-level scores, sgRNA count QC, replicate correlation, hit prioritization, and pathway GSEA' — which comprehensively cover the skill's capability surface, matching the 5-anchor 'multiple specific concrete actions' example.

Completeness

Explicitly answers both: the first sentence states what it does, and 'Use for genome-wide essentiality screens, synthetic-lethality discovery, dropout vs positive-selection screen analysis, target identification, and resistance-screen interpretation' gives concrete when-triggers, matching the 5-anchor example structure.

Trigger Term Quality

Good natural-phrase coverage: 'genome-wide essentiality screens', 'synthetic-lethality discovery', 'dropout vs positive-selection screen', 'resistance-screen interpretation', 'target identification'. A few common variants users would say ('knockout screen', 'sgRNA screen', 'DepMap') are missing, so it sits between anchors 4 and 5, closer to 4.

Distinctiveness Conflict Risk

A clear niche (CRISPR-Cas9 genetic screens) with distinct domain-specific triggers (MAGeCK, sgRNA, synthetic lethality, DepMap-adjacent terms) that no neighboring bioinformatics skill would claim; minimal conflict risk.